System vaccinology for the evaluation of influenza vaccine safety by multiplex gene detection of novel biomarkers in a preclinical study and batch release test.
Vaccines are beneficial and universal tools to prevent infectious disease. Thus, safety of vaccines is strictly evaluated in the preclinical phase of trials and every vaccine batch must be tested by the National Control Laboratories according to the guidelines published by each country. Despite many...
Main Authors: | Takuo Mizukami, Haruka Momose, Madoka Kuramitsu, Kazuya Takizawa, Kumiko Araki, Keiko Furuhata, Ken J Ishii, Isao Hamaguchi, Kazunari Yamaguchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4092028?pdf=render |
Similar Items
-
Establishment of a new quality control and vaccine safety test for influenza vaccines and adjuvants using gene expression profiling.
by: Haruka Momose, et al.
Published: (2015-01-01) -
A New Method for the Evaluation of Vaccine Safety Based on Comprehensive Gene Expression Analysis
by: Haruka Momose, et al.
Published: (2010-01-01) -
Immunogenicity and Toxicity of Different Adjuvants Can Be Characterized by Profiling Lung Biomarker Genes After Nasal Immunization
by: Eita Sasaki, et al.
Published: (2020-09-01) -
Modeling for influenza vaccines and adjuvants profile for safety prediction system using gene expression profiling and statistical tools.
by: Eita Sasaki, et al.
Published: (2018-01-01) -
In vitro marker gene expression analyses in human peripheral blood mononuclear cells: A tool to assess safety of influenza vaccines in humans
by: Eita Sasaki, et al.
Published: (2018-01-01)